

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.89861386 |
| 2 | cytidine deamination (GO:0009972) | 4.00769451 |
| 3 | cytidine metabolic process (GO:0046087) | 4.00769451 |
| 4 | cytidine catabolic process (GO:0006216) | 4.00769451 |
| 5 | muscle filament sliding (GO:0030049) | 3.95814448 |
| 6 | actin-myosin filament sliding (GO:0033275) | 3.95814448 |
| 7 | regulation of regulatory T cell differentiation (GO:0045589) | 3.62233462 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60319341 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60319341 |
| 10 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.60023169 |
| 11 | synaptic vesicle maturation (GO:0016188) | 3.55950236 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 3.55943729 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.51041507 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 3.45882754 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.44973705 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.42409048 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 3.31730496 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 3.31730496 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 3.28026104 |
| 20 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.22946366 |
| 21 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.22111024 |
| 22 | activation of protein kinase A activity (GO:0034199) | 3.22029295 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.20731339 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18514428 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.18229109 |
| 26 | activated T cell proliferation (GO:0050798) | 3.13394591 |
| 27 | regulation of memory T cell differentiation (GO:0043380) | 3.12569231 |
| 28 | DNA deamination (GO:0045006) | 3.11701918 |
| 29 | sodium ion export (GO:0071436) | 3.10119205 |
| 30 | sarcomere organization (GO:0045214) | 3.06883619 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.06178444 |
| 32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.03770991 |
| 33 | actin-mediated cell contraction (GO:0070252) | 3.03356838 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.02575746 |
| 35 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.94864383 |
| 36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.93176755 |
| 37 | skeletal muscle contraction (GO:0003009) | 2.93170610 |
| 38 | oxaloacetate metabolic process (GO:0006107) | 2.92691496 |
| 39 | skeletal muscle fiber development (GO:0048741) | 2.92407195 |
| 40 | stress fiber assembly (GO:0043149) | 2.92258301 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.90341832 |
| 42 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88126906 |
| 43 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88126906 |
| 44 | regulation of skeletal muscle contraction (GO:0014819) | 2.85342407 |
| 45 | neutrophil activation (GO:0042119) | 2.85150649 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84674650 |
| 47 | negative regulation of cell killing (GO:0031342) | 2.84674650 |
| 48 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.84541201 |
| 49 | synaptic vesicle exocytosis (GO:0016079) | 2.80285401 |
| 50 | barbed-end actin filament capping (GO:0051016) | 2.77147529 |
| 51 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.77103027 |
| 52 | actin nucleation (GO:0045010) | 2.76486035 |
| 53 | glutamate secretion (GO:0014047) | 2.76427359 |
| 54 | positive regulation of myotube differentiation (GO:0010831) | 2.73710347 |
| 55 | B cell mediated immunity (GO:0019724) | 2.73665738 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.70921593 |
| 57 | regulation of activation of Janus kinase activity (GO:0010533) | 2.70743170 |
| 58 | protein targeting to plasma membrane (GO:0072661) | 2.70456508 |
| 59 | granulocyte activation (GO:0036230) | 2.70016517 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69760002 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.68847299 |
| 62 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.68795152 |
| 63 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.67895856 |
| 64 | locomotory exploration behavior (GO:0035641) | 2.67609642 |
| 65 | protein localization to endosome (GO:0036010) | 2.66713304 |
| 66 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.66081521 |
| 67 | negative regulation of cell size (GO:0045792) | 2.65550240 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.65523768 |
| 69 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65428270 |
| 70 | regulation of cell killing (GO:0031341) | 2.64856638 |
| 71 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.63999522 |
| 72 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.63865698 |
| 73 | positive regulation of cell killing (GO:0031343) | 2.63335268 |
| 74 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.63315831 |
| 75 | actin filament-based movement (GO:0030048) | 2.61381240 |
| 76 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.60985105 |
| 77 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.60764320 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.60581936 |
| 79 | tricarboxylic acid cycle (GO:0006099) | 2.59262192 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 2.59127309 |
| 81 | mast cell activation (GO:0045576) | 2.58594946 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 2.58144168 |
| 83 | leukocyte degranulation (GO:0043299) | 2.57798951 |
| 84 | NADH metabolic process (GO:0006734) | 2.57660124 |
| 85 | positive T cell selection (GO:0043368) | 2.57368891 |
| 86 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.57175301 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 2.56892148 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55393204 |
| 89 | negative regulation of fatty acid transport (GO:2000192) | 2.54735040 |
| 90 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.54533093 |
| 91 | regulation of defense response to virus by virus (GO:0050690) | 2.53717678 |
| 92 | negative regulation of T cell apoptotic process (GO:0070233) | 2.53706281 |
| 93 | regulation of germinal center formation (GO:0002634) | 2.53093406 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51594000 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51331496 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 2.50084381 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.48834682 |
| 98 | T cell migration (GO:0072678) | 2.48479302 |
| 99 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.47187593 |
| 100 | thrombin receptor signaling pathway (GO:0070493) | 2.47090498 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46631817 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46413033 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.46169066 |
| 104 | cell communication by electrical coupling (GO:0010644) | 2.46132786 |
| 105 | positive regulation of defense response to virus by host (GO:0002230) | 2.45054891 |
| 106 | striated muscle contraction (GO:0006941) | 2.44772405 |
| 107 | T cell costimulation (GO:0031295) | 2.42750955 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.41431210 |
| 109 | signal complex assembly (GO:0007172) | 2.41423230 |
| 110 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.41196147 |
| 111 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.40788472 |
| 112 | response to interferon-beta (GO:0035456) | 2.40494108 |
| 113 | protein neddylation (GO:0045116) | 2.40111569 |
| 114 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.39541250 |
| 115 | lymphocyte costimulation (GO:0031294) | 2.39129143 |
| 116 | positive regulation of axon extension (GO:0045773) | 2.38816535 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38558022 |
| 118 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.38532635 |
| 119 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.38415817 |
| 120 | negative T cell selection (GO:0043383) | 2.37635051 |
| 121 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.36438679 |
| 122 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.36438679 |
| 123 | positive regulation of tolerance induction (GO:0002645) | 2.36333339 |
| 124 | myotube cell development (GO:0014904) | 2.36083826 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.35680049 |
| 126 | regulation of synaptic vesicle transport (GO:1902803) | 2.34988630 |
| 127 | positive regulation of fibroblast migration (GO:0010763) | 2.34932216 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.34566135 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.34249837 |
| 130 | negative thymic T cell selection (GO:0045060) | 2.34184368 |
| 131 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34023733 |
| 132 | regulation of T cell chemotaxis (GO:0010819) | 2.33930552 |
| 133 | positive regulation of T cell chemotaxis (GO:0010820) | 2.33930552 |
| 134 | positive regulation of macrophage differentiation (GO:0045651) | 2.33441230 |
| 135 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.32777237 |
| 136 | platelet dense granule organization (GO:0060155) | 2.32554345 |
| 137 | cardiac muscle contraction (GO:0060048) | 2.32274551 |
| 138 | regulation of relaxation of muscle (GO:1901077) | 2.31619594 |
| 139 | regulation of interleukin-8 secretion (GO:2000482) | 2.31518492 |
| 140 | positive regulation of lymphocyte migration (GO:2000403) | 2.31332446 |
| 141 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.31108556 |
| 142 | positive regulation of myoblast differentiation (GO:0045663) | 2.30695902 |
| 143 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.30209193 |
| 144 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.29924900 |
| 145 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.29842161 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.29778055 |
| 147 | regulation of calcium-mediated signaling (GO:0050848) | 2.29550740 |
| 148 | T cell receptor signaling pathway (GO:0050852) | 2.29463125 |
| 149 | positive regulation of mast cell activation (GO:0033005) | 2.29461993 |
| 150 | dendritic cell chemotaxis (GO:0002407) | 2.29375545 |
| 151 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.28705228 |
| 152 | dendritic cell migration (GO:0036336) | 2.28448280 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.28445872 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.28445509 |
| 155 | muscle fiber development (GO:0048747) | 2.28368551 |
| 156 | apoptotic cell clearance (GO:0043277) | 2.28035657 |
| 157 | B cell receptor signaling pathway (GO:0050853) | 2.27092147 |
| 158 | heterotypic cell-cell adhesion (GO:0034113) | 2.26950054 |
| 159 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.26443890 |
| 160 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.26397584 |
| 161 | regulation of mast cell activation (GO:0033003) | 2.25416337 |
| 162 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.25324049 |
| 163 | positive regulation of lamellipodium assembly (GO:0010592) | 2.24955716 |
| 164 | cellular defense response (GO:0006968) | 2.24163150 |
| 165 | potassium ion import (GO:0010107) | 2.24154811 |
| 166 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.22602442 |
| 167 | regulation of tight junction assembly (GO:2000810) | 2.22492724 |
| 168 | actomyosin structure organization (GO:0031032) | 2.22068761 |
| 169 | thymic T cell selection (GO:0045061) | 2.19421157 |
| 170 | regulation of ARF protein signal transduction (GO:0032012) | 2.17794869 |
| 171 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.16773327 |
| 172 | positive thymic T cell selection (GO:0045059) | 2.16622225 |
| 173 | proline transport (GO:0015824) | 2.16240451 |
| 174 | muscle contraction (GO:0006936) | 2.15892547 |
| 175 | cardiac myofibril assembly (GO:0055003) | 2.14361260 |
| 176 | membrane raft organization (GO:0031579) | 2.10796174 |
| 177 | succinate metabolic process (GO:0006105) | 2.10666315 |
| 178 | positive regulation of vesicle fusion (GO:0031340) | 2.10047004 |
| 179 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.07870285 |
| 180 | endocytic recycling (GO:0032456) | 2.07825585 |
| 181 | syncytium formation (GO:0006949) | 2.07245462 |
| 182 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.06475979 |
| 183 | vocalization behavior (GO:0071625) | 2.05849785 |
| 184 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.05799756 |
| 185 | cell communication involved in cardiac conduction (GO:0086065) | 2.05707937 |
| 186 | response to interleukin-15 (GO:0070672) | 2.05084354 |
| 187 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.04413322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.77645875 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.08954914 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00974917 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91942147 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84308712 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69052327 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39493045 |
| 8 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28183717 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26163270 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.24506534 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08701500 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08670359 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03614433 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98140576 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94930493 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91831786 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87670126 |
| 18 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.85834067 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.81934177 |
| 20 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80516878 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79747298 |
| 22 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.73796919 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72400111 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.72336789 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.68324782 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65464529 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64311942 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60644292 |
| 29 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.59896570 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59074328 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58020132 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55225121 |
| 33 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55078773 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54791393 |
| 35 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53652575 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.52737808 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52121894 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51971426 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51695770 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50919716 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50668683 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50384643 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49572168 |
| 44 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47947300 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47708810 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47216486 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46477967 |
| 48 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46185073 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45631253 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45212218 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44959404 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44645599 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43515451 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43339037 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41861298 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40510790 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40114430 |
| 58 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39554361 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38440002 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37824350 |
| 61 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37658247 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35929750 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35754541 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35537397 |
| 65 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35140915 |
| 66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34151523 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34151523 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33769933 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33732346 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31435268 |
| 71 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.30429928 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29583792 |
| 73 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29323901 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28769678 |
| 75 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27368183 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25345884 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22904936 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21803993 |
| 79 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21565777 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21319376 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20277290 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19359842 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16644728 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16313569 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16282912 |
| 86 | * MYB_26560356_Chip-Seq_TH1_Human | 1.15779017 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15498130 |
| 88 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12701730 |
| 89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12308305 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12077831 |
| 91 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11364379 |
| 92 | * MYB_26560356_Chip-Seq_TH2_Human | 1.10340093 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09925625 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09887598 |
| 95 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09609371 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09326831 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09326831 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08003190 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07822753 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07679557 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06850561 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06594312 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06105249 |
| 104 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06063935 |
| 105 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05874957 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04740862 |
| 107 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04557338 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.04365020 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04082234 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03945493 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03508973 |
| 112 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03489000 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02406926 |
| 114 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00865668 |
| 115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00687727 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00314829 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00252665 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99840363 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99780038 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99749701 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99707154 |
| 122 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99668421 |
| 123 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98367603 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98102726 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97889060 |
| 126 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97830203 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97767019 |
| 128 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97351277 |
| 129 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97351277 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97059688 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96787634 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96604822 |
| 133 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96562828 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96198253 |
| 135 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95964268 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94873182 |
| 137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94257898 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94069065 |
| 139 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94011195 |
| 140 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93692177 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92381635 |
| 142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92015276 |
| 143 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91140755 |
| 144 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85809885 |
| 145 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85004327 |
| 146 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85004327 |
| 147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84464318 |
| 148 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84114481 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81204311 |
| 150 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81188713 |
| 151 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80773180 |
| 152 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80674175 |
| 153 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80146395 |
| 154 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79620918 |
| 155 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78758703 |
| 156 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78368582 |
| 157 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77808308 |
| 158 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77760758 |
| 159 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77218005 |
| 160 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77063876 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76891679 |
| 162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76619050 |
| 163 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76293885 |
| 164 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75537590 |
| 165 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75386328 |
| 166 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75208233 |
| 167 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74632821 |
| 168 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74525260 |
| 169 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73499048 |
| 170 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73499048 |
| 171 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.73314033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.86015258 |
| 2 | MP0000751_myopathy | 3.56322085 |
| 3 | MP0000749_muscle_degeneration | 3.06221575 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.06103800 |
| 5 | MP0009785_altered_susceptibility_to | 2.77351622 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.70866233 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.65819643 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.57948191 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.27778041 |
| 10 | MP0001800_abnormal_humoral_immune | 2.26010300 |
| 11 | MP0000747_muscle_weakness | 2.25765996 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.23912554 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.21084351 |
| 14 | MP0002723_abnormal_immune_serum | 2.16444255 |
| 15 | MP0005025_abnormal_response_to | 2.13593177 |
| 16 | MP0004130_abnormal_muscle_cell | 2.11325720 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.09649383 |
| 18 | MP0004510_myositis | 2.08824939 |
| 19 | MP0004270_analgesia | 2.07626525 |
| 20 | MP0003303_peritoneal_inflammation | 2.07084988 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.04252386 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.00673198 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.98077089 |
| 24 | MP0003279_aneurysm | 1.97253584 |
| 25 | MP0004087_abnormal_muscle_fiber | 1.95896553 |
| 26 | MP0001819_abnormal_immune_cell | 1.94091303 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.93618979 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.91151776 |
| 29 | MP0004858_abnormal_nervous_system | 1.88621839 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.87358745 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.80190505 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.74767303 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.72566713 |
| 34 | MP0000733_abnormal_muscle_development | 1.72212304 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.67580874 |
| 36 | MP0003329_amyloid_beta_deposits | 1.67323078 |
| 37 | MP0001958_emphysema | 1.63630629 |
| 38 | MP0002405_respiratory_system_inflammati | 1.63547629 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.62440867 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.61174268 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.59631277 |
| 42 | MP0002269_muscular_atrophy | 1.57660041 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.56012357 |
| 44 | MP0003866_abnormal_defecation | 1.54839080 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.52114690 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.50968838 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.48956962 |
| 48 | MP0002736_abnormal_nociception_after | 1.47769132 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.47371139 |
| 50 | MP0000604_amyloidosis | 1.47019572 |
| 51 | MP0005275_abnormal_skin_tensile | 1.43831048 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.42000951 |
| 53 | MP0003646_muscle_fatigue | 1.40205859 |
| 54 | MP0005369_muscle_phenotype | 1.39743083 |
| 55 | MP0005330_cardiomyopathy | 1.38868658 |
| 56 | MP0005623_abnormal_meninges_morphology | 1.38350567 |
| 57 | MP0003075_altered_response_to | 1.37804384 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.36960072 |
| 59 | MP0000716_abnormal_immune_system | 1.36759318 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.34551052 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.33274142 |
| 62 | MP0002398_abnormal_bone_marrow | 1.32424844 |
| 63 | MP0004233_abnormal_muscle_weight | 1.31911832 |
| 64 | MP0002972_abnormal_cardiac_muscle | 1.31879040 |
| 65 | MP0003045_fibrosis | 1.30977888 |
| 66 | MP0003091_abnormal_cell_migration | 1.25858213 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.20424604 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.20147285 |
| 69 | MP0003436_decreased_susceptibility_to | 1.19755068 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.19541298 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.19379390 |
| 72 | MP0004484_altered_response_of | 1.18228766 |
| 73 | MP0009764_decreased_sensitivity_to | 1.18135509 |
| 74 | MP0008469_abnormal_protein_level | 1.17585383 |
| 75 | MP0008569_lethality_at_weaning | 1.17177557 |
| 76 | MP0010386_abnormal_urinary_bladder | 1.16413754 |
| 77 | MP0003828_pulmonary_edema | 1.14029305 |
| 78 | MP0000343_altered_response_to | 1.13504191 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.10278074 |
| 80 | MP0003879_abnormal_hair_cell | 1.09870332 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 1.08062321 |
| 82 | MP0005310_abnormal_salivary_gland | 1.07862740 |
| 83 | MP0000685_abnormal_immune_system | 1.06883857 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.06176095 |
| 85 | MP0009763_increased_sensitivity_to | 1.05550115 |
| 86 | MP0006054_spinal_hemorrhage | 1.05317861 |
| 87 | MP0002722_abnormal_immune_system | 1.02611503 |
| 88 | MP0003195_calcinosis | 1.01915698 |
| 89 | MP0002429_abnormal_blood_cell | 1.01439683 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 1.00924780 |
| 91 | MP0002064_seizures | 1.00200100 |
| 92 | MP0002933_joint_inflammation | 0.98897431 |
| 93 | MP0002006_tumorigenesis | 0.98728072 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.97380911 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.95650913 |
| 96 | MP0001542_abnormal_bone_strength | 0.95553704 |
| 97 | MP0005166_decreased_susceptibility_to | 0.95288657 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.93813996 |
| 99 | MP0008775_abnormal_heart_ventricle | 0.93214032 |
| 100 | MP0005023_abnormal_wound_healing | 0.93143616 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.92926670 |
| 102 | MP0000858_altered_metastatic_potential | 0.92707674 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.92647157 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.91992217 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.91992217 |
| 106 | MP0002108_abnormal_muscle_morphology | 0.91703401 |
| 107 | MP0001853_heart_inflammation | 0.91660238 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.91608143 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.91156995 |
| 110 | MP0004947_skin_inflammation | 0.90976249 |
| 111 | MP0003448_altered_tumor_morphology | 0.90719591 |
| 112 | MP0009745_abnormal_behavioral_response | 0.90664148 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.90152252 |
| 114 | MP0005000_abnormal_immune_tolerance | 0.89941135 |
| 115 | MP0005535_abnormal_body_temperature | 0.89194481 |
| 116 | MP0003011_delayed_dark_adaptation | 0.88365573 |
| 117 | MP0001835_abnormal_antigen_presentation | 0.87929690 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.87921717 |
| 119 | MP0001851_eye_inflammation | 0.87643534 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.87385657 |
| 121 | MP0004811_abnormal_neuron_physiology | 0.87339152 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.87249045 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.86924232 |
| 124 | MP0005671_abnormal_response_to | 0.86822519 |
| 125 | MP0005503_abnormal_tendon_morphology | 0.86782138 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.86685924 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.86161220 |
| 128 | MP0006082_CNS_inflammation | 0.86030193 |
| 129 | MP0001790_abnormal_immune_system | 0.85694455 |
| 130 | MP0005387_immune_system_phenotype | 0.85694455 |
| 131 | MP0000920_abnormal_myelination | 0.85573001 |
| 132 | MP0008874_decreased_physiological_sensi | 0.83089488 |
| 133 | MP0000249_abnormal_blood_vessel | 0.83008281 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.82024600 |
| 135 | MP0003633_abnormal_nervous_system | 0.81844951 |
| 136 | MP0001970_abnormal_pain_threshold | 0.81127075 |
| 137 | MP0002089_abnormal_postnatal_growth/wei | 0.80963729 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.80606715 |
| 139 | MP0005165_increased_susceptibility_to | 0.80605544 |
| 140 | MP0005164_abnormal_response_to | 0.79856151 |
| 141 | MP0005390_skeleton_phenotype | 0.78339723 |
| 142 | MP0010352_gastrointestinal_tract_polyps | 0.78325206 |
| 143 | MP0000703_abnormal_thymus_morphology | 0.77627207 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.77589502 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.76708306 |
| 146 | MP0003690_abnormal_glial_cell | 0.74902386 |
| 147 | MP0002419_abnormal_innate_immunity | 0.74531674 |
| 148 | MP0004883_abnormal_blood_vessel | 0.74371470 |
| 149 | MP0000569_abnormal_digit_pigmentation | 0.73923319 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.73019860 |
| 151 | MP0001905_abnormal_dopamine_level | 0.72974911 |
| 152 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72213865 |
| 153 | MP0002896_abnormal_bone_mineralization | 0.72188327 |
| 154 | MP0003763_abnormal_thymus_physiology | 0.72093884 |
| 155 | MP0008004_abnormal_stomach_pH | 0.71726056 |
| 156 | MP0002420_abnormal_adaptive_immunity | 0.71380298 |
| 157 | MP0001873_stomach_inflammation | 0.71191753 |
| 158 | MP0000015_abnormal_ear_pigmentation | 0.70686579 |
| 159 | MP0005397_hematopoietic_system_phenotyp | 0.69607362 |
| 160 | MP0001545_abnormal_hematopoietic_system | 0.69607362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.60414408 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 4.55912607 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.53319771 |
| 4 | Nemaline bodies (HP:0003798) | 4.18905368 |
| 5 | Distal arthrogryposis (HP:0005684) | 4.08767459 |
| 6 | Petechiae (HP:0000967) | 3.92802251 |
| 7 | Prolonged bleeding time (HP:0003010) | 3.85087248 |
| 8 | Stomatitis (HP:0010280) | 3.82345018 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.74804691 |
| 10 | T lymphocytopenia (HP:0005403) | 3.73040208 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58797900 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.58195578 |
| 13 | Ulnar deviation of the wrist (HP:0003049) | 3.54668477 |
| 14 | Round ear (HP:0100830) | 3.51670418 |
| 15 | Fetal akinesia sequence (HP:0001989) | 3.48513532 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.48152515 |
| 17 | Purpura (HP:0000979) | 3.47746521 |
| 18 | Myositis (HP:0100614) | 3.34754651 |
| 19 | Difficulty running (HP:0009046) | 3.32935137 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.32351964 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.28280169 |
| 22 | Difficulty climbing stairs (HP:0003551) | 3.24277748 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20876754 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20876754 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20876754 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 3.16608195 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.15707386 |
| 28 | Increased connective tissue (HP:0009025) | 3.14108198 |
| 29 | Epistaxis (HP:0000421) | 3.13081680 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.12176411 |
| 31 | Protrusio acetabuli (HP:0003179) | 3.09065216 |
| 32 | Myopathic facies (HP:0002058) | 3.02695865 |
| 33 | Optic neuritis (HP:0100653) | 3.02299123 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.02299123 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.99670977 |
| 36 | Increased IgM level (HP:0003496) | 2.98933250 |
| 37 | Myotonia (HP:0002486) | 2.97610538 |
| 38 | Frequent falls (HP:0002359) | 2.96153142 |
| 39 | Orchitis (HP:0100796) | 2.95472849 |
| 40 | Gingival bleeding (HP:0000225) | 2.94098140 |
| 41 | Malignant hyperthermia (HP:0002047) | 2.90232860 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.87909899 |
| 43 | IgG deficiency (HP:0004315) | 2.85335556 |
| 44 | Abnormality of T cells (HP:0002843) | 2.81856783 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.81154600 |
| 46 | Abnormality of the calf musculature (HP:0001430) | 2.80697864 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.78436385 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.75034989 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.72991021 |
| 50 | Abnormality of the prostate (HP:0008775) | 2.69677204 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.66816890 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.66330098 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.65810640 |
| 54 | Joint swelling (HP:0001386) | 2.65747625 |
| 55 | Calf muscle hypertrophy (HP:0008981) | 2.65685869 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62280115 |
| 57 | Encephalitis (HP:0002383) | 2.61231335 |
| 58 | Fatigable weakness (HP:0003473) | 2.57363058 |
| 59 | Abnormality of the neuromuscular junction (HP:0003398) | 2.57363058 |
| 60 | Vasculitis (HP:0002633) | 2.55838266 |
| 61 | Increased density of long bones (HP:0006392) | 2.54120925 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.53571460 |
| 63 | Akinesia (HP:0002304) | 2.49841255 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48331298 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48331298 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.48086553 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.47573180 |
| 68 | Premature rupture of membranes (HP:0001788) | 2.46464957 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.46253069 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.45602300 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.44879446 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44486141 |
| 73 | Obstructive lung disease (HP:0006536) | 2.44486141 |
| 74 | Hemoptysis (HP:0002105) | 2.44168076 |
| 75 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.43642926 |
| 76 | Abnormal platelet volume (HP:0011876) | 2.42360606 |
| 77 | Eosinophilia (HP:0001880) | 2.41842004 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.41662381 |
| 79 | Menorrhagia (HP:0000132) | 2.39013713 |
| 80 | Chronic diarrhea (HP:0002028) | 2.38489365 |
| 81 | Leukocytosis (HP:0001974) | 2.38253840 |
| 82 | Pustule (HP:0200039) | 2.38050135 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.37766939 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35712413 |
| 85 | Scapular winging (HP:0003691) | 2.35558862 |
| 86 | Meningitis (HP:0001287) | 2.35491570 |
| 87 | Aortic aneurysm (HP:0004942) | 2.34762990 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.34445380 |
| 89 | Distal upper limb amyotrophy (HP:0007149) | 2.34445380 |
| 90 | Popliteal pterygium (HP:0009756) | 2.34034531 |
| 91 | Sudden death (HP:0001699) | 2.33808223 |
| 92 | Gowers sign (HP:0003391) | 2.33179225 |
| 93 | Striae distensae (HP:0001065) | 2.32712564 |
| 94 | Lower limb amyotrophy (HP:0007210) | 2.32318698 |
| 95 | Chest pain (HP:0100749) | 2.32144717 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.31187376 |
| 97 | Increased mean platelet volume (HP:0011877) | 2.25752315 |
| 98 | Myoglobinuria (HP:0002913) | 2.25457681 |
| 99 | Recurrent skin infections (HP:0001581) | 2.24618645 |
| 100 | Calcaneovalgus deformity (HP:0001848) | 2.22020766 |
| 101 | Facial diplegia (HP:0001349) | 2.21381162 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.20898684 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.18730481 |
| 104 | Dilatation of the ascending aorta (HP:0005111) | 2.18425216 |
| 105 | Spinal rigidity (HP:0003306) | 2.17779773 |
| 106 | Pulmonary embolism (HP:0002204) | 2.16206090 |
| 107 | Pulmonary fibrosis (HP:0002206) | 2.15515851 |
| 108 | Slender build (HP:0001533) | 2.14858439 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 2.10469813 |
| 110 | Granulocytopenia (HP:0001913) | 2.09685666 |
| 111 | Absent phalangeal crease (HP:0006109) | 2.08988711 |
| 112 | Achilles tendon contracture (HP:0001771) | 2.08672569 |
| 113 | Aortic dissection (HP:0002647) | 2.08572840 |
| 114 | Muscle stiffness (HP:0003552) | 2.08215175 |
| 115 | Hypercortisolism (HP:0001578) | 2.07083154 |
| 116 | Bulbar palsy (HP:0001283) | 2.06618446 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 2.06305420 |
| 118 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05763430 |
| 119 | Easy fatigability (HP:0003388) | 2.05467468 |
| 120 | Neck muscle weakness (HP:0000467) | 2.05086657 |
| 121 | Keratoconjunctivitis (HP:0001096) | 2.04966333 |
| 122 | Hypoproteinemia (HP:0003075) | 2.04093367 |
| 123 | Deformed tarsal bones (HP:0008119) | 2.04063719 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 2.03119051 |
| 125 | Thyroiditis (HP:0100646) | 2.02076954 |
| 126 | Urticaria (HP:0001025) | 2.01930245 |
| 127 | Gangrene (HP:0100758) | 1.99755718 |
| 128 | Metaphyseal dysplasia (HP:0100255) | 1.97426463 |
| 129 | Abnormality of binocular vision (HP:0011514) | 1.97243105 |
| 130 | Diplopia (HP:0000651) | 1.97243105 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.97141294 |
| 132 | Type 2 muscle fiber atrophy (HP:0003554) | 1.96412836 |
| 133 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96243096 |
| 134 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96243096 |
| 135 | Polyneuropathy (HP:0001271) | 1.96215294 |
| 136 | Arterial thrombosis (HP:0004420) | 1.96097359 |
| 137 | Muscle fiber atrophy (HP:0100295) | 1.95997513 |
| 138 | Severe combined immunodeficiency (HP:0004430) | 1.94797758 |
| 139 | Hematochezia (HP:0002573) | 1.93598862 |
| 140 | Weak cry (HP:0001612) | 1.92728849 |
| 141 | Vertebral compression fractures (HP:0002953) | 1.91018814 |
| 142 | Broad metatarsal (HP:0001783) | 1.90304318 |
| 143 | Pheochromocytoma (HP:0002666) | 1.89859191 |
| 144 | Vertigo (HP:0002321) | 1.89766198 |
| 145 | Rapidly progressive (HP:0003678) | 1.89057280 |
| 146 | Myokymia (HP:0002411) | 1.87974076 |
| 147 | Abnormality of the Achilles tendon (HP:0005109) | 1.86934074 |
| 148 | Palpitations (HP:0001962) | 1.86550621 |
| 149 | Bundle branch block (HP:0011710) | 1.85612091 |
| 150 | Renal cortical cysts (HP:0000803) | 1.85048049 |
| 151 | Acute hepatic failure (HP:0006554) | 1.84842164 |
| 152 | Autoimmune thrombocytopenia (HP:0001973) | 1.83738068 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83605519 |
| 154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83605519 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83605519 |
| 156 | Agammaglobulinemia (HP:0004432) | 1.83306149 |
| 157 | Dysmetric saccades (HP:0000641) | 1.82770389 |
| 158 | Thin ribs (HP:0000883) | 1.82319222 |
| 159 | Visual hallucinations (HP:0002367) | 1.81975918 |
| 160 | Generalized muscle weakness (HP:0003324) | 1.81260088 |
| 161 | Abnormality of the calcaneus (HP:0008364) | 1.80332801 |
| 162 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80052445 |
| 163 | Abnormal platelet function (HP:0011869) | 1.79191406 |
| 164 | Impaired platelet aggregation (HP:0003540) | 1.79191406 |
| 165 | Rhabdomyolysis (HP:0003201) | 1.78774620 |
| 166 | Abnormality of placental membranes (HP:0011409) | 1.78237819 |
| 167 | Amniotic constriction ring (HP:0009775) | 1.78237819 |
| 168 | Distal lower limb muscle weakness (HP:0009053) | 1.77531226 |
| 169 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75977438 |
| 170 | Glomerulopathy (HP:0100820) | 1.75913620 |
| 171 | Right ventricular cardiomyopathy (HP:0011663) | 1.75641305 |
| 172 | Premature loss of primary teeth (HP:0006323) | 1.75092663 |
| 173 | Anorexia (HP:0002039) | 1.74896727 |
| 174 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74419330 |
| 175 | Mucopolysacchariduria (HP:0008155) | 1.74419330 |
| 176 | Papilledema (HP:0001085) | 1.73694834 |
| 177 | EMG: neuropathic changes (HP:0003445) | 1.72956827 |
| 178 | Spinal canal stenosis (HP:0003416) | 1.72397276 |
| 179 | Progressive neurologic deterioration (HP:0002344) | 1.71501753 |
| 180 | Neuroendocrine neoplasm (HP:0100634) | 1.71294315 |
| 181 | Systemic lupus erythematosus (HP:0002725) | 1.71077081 |
| 182 | Episodic fever (HP:0001954) | 1.70626273 |
| 183 | Cervical subluxation (HP:0003308) | 1.67683495 |
| 184 | Long toe (HP:0010511) | 1.67591140 |
| 185 | Dysostosis multiplex (HP:0000943) | 1.67521109 |
| 186 | Vascular tortuosity (HP:0004948) | 1.66920968 |
| 187 | Joint stiffness (HP:0001387) | 1.66042046 |
| 188 | Abnormality of the nasal mucosa (HP:0000433) | 1.64462963 |
| 189 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64015150 |
| 190 | Resting tremor (HP:0002322) | 1.62681472 |
| 191 | Arterial tortuosity (HP:0005116) | 1.61018841 |
| 192 | Atonic seizures (HP:0010819) | 1.60873401 |
| 193 | Ankle contracture (HP:0006466) | 1.59504143 |
| 194 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.59334956 |
| 195 | Subaortic stenosis (HP:0001682) | 1.59242238 |
| 196 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.59242238 |
| 197 | Shallow orbits (HP:0000586) | 1.59069525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.58297718 |
| 2 | PKN2 | 3.42348707 |
| 3 | TTN | 3.37696703 |
| 4 | RIPK4 | 2.57519893 |
| 5 | TAOK3 | 2.36023575 |
| 6 | TESK2 | 2.14014047 |
| 7 | MST4 | 2.10543843 |
| 8 | KSR2 | 1.95062646 |
| 9 | MAP3K9 | 1.88366272 |
| 10 | BMPR2 | 1.86409657 |
| 11 | EEF2K | 1.79907226 |
| 12 | ERN1 | 1.78889950 |
| 13 | MAP3K14 | 1.78038022 |
| 14 | ADRBK2 | 1.75732425 |
| 15 | TEC | 1.74141171 |
| 16 | GRK6 | 1.73656478 |
| 17 | CAMKK1 | 1.69716979 |
| 18 | RIPK1 | 1.64023445 |
| 19 | DAPK2 | 1.59413803 |
| 20 | MOS | 1.55847864 |
| 21 | MAP4K1 | 1.53182100 |
| 22 | NEK1 | 1.52487746 |
| 23 | IKBKE | 1.51399539 |
| 24 | CSK | 1.51060421 |
| 25 | LRRK2 | 1.50583371 |
| 26 | CSF1R | 1.49006399 |
| 27 | IKBKB | 1.47871186 |
| 28 | TAOK1 | 1.46856842 |
| 29 | MAP4K2 | 1.46378420 |
| 30 | PRKCH | 1.46374792 |
| 31 | BCKDK | 1.46102126 |
| 32 | GRK7 | 1.44471917 |
| 33 | MAP3K12 | 1.42104156 |
| 34 | BTK | 1.40748166 |
| 35 | PAK6 | 1.38170581 |
| 36 | CAMKK2 | 1.38018708 |
| 37 | PHKG1 | 1.37874837 |
| 38 | PHKG2 | 1.37874837 |
| 39 | RET | 1.36632432 |
| 40 | PIK3CG | 1.35157927 |
| 41 | FGFR4 | 1.33593331 |
| 42 | JAK1 | 1.31316598 |
| 43 | OBSCN | 1.28424952 |
| 44 | LMTK2 | 1.26240349 |
| 45 | MAPKAPK3 | 1.25112644 |
| 46 | FRK | 1.24180637 |
| 47 | MAP2K3 | 1.20966141 |
| 48 | GRK5 | 1.19789380 |
| 49 | TNK2 | 1.18333849 |
| 50 | NTRK3 | 1.18330702 |
| 51 | SIK3 | 1.17779591 |
| 52 | BLK | 1.17715465 |
| 53 | TBK1 | 1.17128122 |
| 54 | LYN | 1.16724901 |
| 55 | LIMK1 | 1.12563533 |
| 56 | MINK1 | 1.12452347 |
| 57 | LCK | 1.11894355 |
| 58 | ILK | 1.10280920 |
| 59 | MUSK | 1.09480729 |
| 60 | ERBB3 | 1.08040775 |
| 61 | PTK6 | 1.06259959 |
| 62 | SCYL2 | 1.03690980 |
| 63 | MAP2K1 | 1.03601346 |
| 64 | PDGFRA | 1.02222513 |
| 65 | PRKCQ | 1.01330951 |
| 66 | ZAP70 | 1.00841290 |
| 67 | NTRK1 | 1.00756871 |
| 68 | MAP3K2 | 0.97363370 |
| 69 | JAK3 | 0.97300109 |
| 70 | MAP3K7 | 0.95981144 |
| 71 | DMPK | 0.95515354 |
| 72 | TESK1 | 0.94628877 |
| 73 | EPHB1 | 0.93694128 |
| 74 | TYK2 | 0.93415922 |
| 75 | ITK | 0.93124923 |
| 76 | DAPK3 | 0.92006096 |
| 77 | MAP3K13 | 0.91978157 |
| 78 | PRKD3 | 0.91100065 |
| 79 | TGFBR2 | 0.90091358 |
| 80 | PIM2 | 0.88057537 |
| 81 | MAPK12 | 0.86822125 |
| 82 | PINK1 | 0.86264191 |
| 83 | ARAF | 0.85397777 |
| 84 | PDK3 | 0.84409737 |
| 85 | PDK4 | 0.84409737 |
| 86 | BCR | 0.83536641 |
| 87 | MYLK | 0.83419649 |
| 88 | TXK | 0.83146338 |
| 89 | PTK2B | 0.81992645 |
| 90 | DAPK1 | 0.81986634 |
| 91 | ALK | 0.81852624 |
| 92 | MAP3K1 | 0.81826313 |
| 93 | DDR2 | 0.81822930 |
| 94 | PDK1 | 0.79957853 |
| 95 | FES | 0.79658222 |
| 96 | KIT | 0.79277657 |
| 97 | GRK1 | 0.78700049 |
| 98 | BMPR1B | 0.77469252 |
| 99 | MAP3K3 | 0.76635540 |
| 100 | SIK1 | 0.74912027 |
| 101 | FGFR3 | 0.74360719 |
| 102 | MAP2K4 | 0.69965709 |
| 103 | MAPK7 | 0.69962766 |
| 104 | PDPK1 | 0.68237824 |
| 105 | CDK19 | 0.67979184 |
| 106 | JAK2 | 0.67178050 |
| 107 | PLK2 | 0.67168112 |
| 108 | PAK4 | 0.67125943 |
| 109 | ADRBK1 | 0.66928094 |
| 110 | PRKCE | 0.66381724 |
| 111 | PTK2 | 0.65916819 |
| 112 | HCK | 0.65641598 |
| 113 | CDK5 | 0.65090058 |
| 114 | IGF1R | 0.65089747 |
| 115 | CDK14 | 0.64978803 |
| 116 | BMX | 0.63817423 |
| 117 | EIF2AK3 | 0.63809233 |
| 118 | PAK3 | 0.63447414 |
| 119 | CDK15 | 0.62677481 |
| 120 | MAP3K4 | 0.62647763 |
| 121 | FYN | 0.62604812 |
| 122 | SIK2 | 0.62598153 |
| 123 | CDK18 | 0.59763224 |
| 124 | FLT3 | 0.58420131 |
| 125 | LATS2 | 0.58149500 |
| 126 | FGR | 0.58133918 |
| 127 | MATK | 0.57769833 |
| 128 | TRPM7 | 0.56197790 |
| 129 | ACVR1B | 0.55481486 |
| 130 | RAF1 | 0.54888472 |
| 131 | NEK9 | 0.54427522 |
| 132 | CDK11A | 0.53987851 |
| 133 | ABL1 | 0.53769437 |
| 134 | MAP3K5 | 0.53618430 |
| 135 | ROCK2 | 0.53229937 |
| 136 | STK38 | 0.50886862 |
| 137 | ROCK1 | 0.50028794 |
| 138 | SYK | 0.48480506 |
| 139 | MAP3K11 | 0.48453482 |
| 140 | FER | 0.48019069 |
| 141 | EPHA3 | 0.47742013 |
| 142 | OXSR1 | 0.47367254 |
| 143 | KDR | 0.45922701 |
| 144 | NUAK1 | 0.45029709 |
| 145 | PRKCD | 0.44450362 |
| 146 | MAPK13 | 0.44060494 |
| 147 | TRIM28 | 0.42723959 |
| 148 | PRKD1 | 0.41871182 |
| 149 | IRAK4 | 0.40405894 |
| 150 | TLK1 | 0.40311596 |
| 151 | IRAK1 | 0.38570056 |
| 152 | STK16 | 0.37897768 |
| 153 | MARK3 | 0.37282773 |
| 154 | CAMK2A | 0.36823134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.52632734 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.31435491 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.23517890 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84678352 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.78691991 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.55101144 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39230025 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37842255 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32617754 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.25871597 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.16522819 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07650390 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.00850719 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.85876651 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.69274539 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63381290 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62299572 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53284948 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48866640 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47395651 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46030527 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45214352 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38244815 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.33714522 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32019870 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.31413895 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30822587 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28980244 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28744147 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28593376 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26691749 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21411556 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21038026 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.20656998 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19967358 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19635147 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18376276 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18278889 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17975977 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.17373250 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17129673 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15002074 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14128901 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13635269 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13603463 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13172276 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11348244 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.11292305 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10821553 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09122771 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07622517 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07597707 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.06577757 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.06403577 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03816116 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03254047 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 1.03051867 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02393307 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 1.01365437 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01347563 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99302820 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.99241614 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98987505 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.97205656 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96716120 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.96174809 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96026486 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95691799 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95590425 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95022448 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.93209109 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93111818 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.92866381 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91795884 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91559773 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90979404 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90890228 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.90097671 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89697388 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88713620 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.87972988 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87929276 |
| 83 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87468591 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86795762 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86406134 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84676480 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84412422 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84409365 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84193008 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.84090065 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84068748 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83697814 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83384566 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82888323 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82167689 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82082391 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.81869150 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81691903 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81343119 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81029742 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.80383369 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78809019 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78719209 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78517708 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77364429 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77262200 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77230162 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74869717 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.73058033 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72529467 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72297960 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72046327 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71238113 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69989839 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.69490707 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69262807 |
| 117 | Protein export_Homo sapiens_hsa03060 | 0.69058041 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68527853 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.68410909 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68356522 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68193222 |
| 122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67903953 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67379829 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66460531 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64880871 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64519827 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63870064 |
| 128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63763791 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62854981 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62671495 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61950472 |
| 132 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61896780 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61739972 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59210306 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58922259 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58756730 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57852792 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57445200 |
| 139 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57112598 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.55987788 |
| 141 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53646271 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49790092 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.48088894 |
| 144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47395318 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46951667 |
| 146 | Influenza A_Homo sapiens_hsa05164 | 0.45775423 |
| 147 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45114697 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45108976 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45065064 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.43875534 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42183648 |
| 152 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39750549 |
| 153 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38152091 |
| 154 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37822711 |
| 155 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37759304 |
| 156 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35352868 |
| 157 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32315615 |
| 158 | Apoptosis_Homo sapiens_hsa04210 | 0.31285441 |
| 159 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29567725 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29113319 |
| 161 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.28922134 |

